Parvo preventative picks up speedDecember 29, 2020Elanco Animal Health is set to acquire the global rights to Kindred Biosciences’ proprietary KIND-030, a monoclonal antibody being developed for the treatment and prevention of canine parvovirus.
SPONSORED CONTENTFight the Flames of Canine OAManaging pain from canine OA doesn’t have to be complicated. Discover an approach that doesn’t just treat pain, but addresses inflammation, too. + Learn More